NEO

#2405
NeoGenomics, Inc.
8.35 USD
+4.37%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
8.35
8.35
Intervallo Annuale
4.72
13.74
Variazione giornaliera
+4.37%
Variazione Mensile
+3.99%
Variazione di 6 mesi
-12.11%
Variazione Annuale
-13.20%
Chiusura Precedente
8.00
Apertura
8.35
Bid
Ask
Minimo
8.35
High
8.35
Volume
75
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 1.08 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-14
Rapporto prezzo/fatturato
2.07

NeoGenomics Inc

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

Notizie